Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections

References

1. Rozenberg-Arska M, Visser MR. Infectious disease therapy in the 1990s. Where are we heading?. Drugs 1992; 43:629–636
   [Google Scholar]
2. Ziegler EJ, Fischer CJ, Sprung CL. et al. Treatment of Gram-negative bacteraemia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1991; 324:429–436
   [Google Scholar]
3. McCabe WR, De Maria A, Berberich H, Johns MA. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to Re595 (Re Chemotype) mutant. J Infect Dis 1988; 158:291–300
   [Google Scholar]
4. Raponi G, Keller N, Overbeek BP, Rozenberg-Arska M, Torensma R, Verhoef J. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. J Infect Dis 1991; 163:122–127
   [Google Scholar]
5. Raponi G, Lun MT, Lorino G. et al. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. J Antimicrob Chemother 1993; 31:117–128
   [Google Scholar]
6. Fazekas De St Groth S, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980; 35:1–21
   [Google Scholar]
7. Overbeek BP, Schellekens JFP, Lippe W, Dekker BAT, Verhoef J. Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough mutant Escherichia coli J5. J Clin Microbiol 1987; 25:1009–1013
   [Google Scholar]
8. Eliasson M, Olsson A, Palmcrantz E. et al. Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem 1988; 263:4323–4327
   [Google Scholar]
9. Schellekens J, Benne CA, De Zeeuw GR, Rozenberg-Arska M, Verhoef J. Natural occurring IgG and IgM antibodies to gram-negative bacteria and lipopolysaccharides in human sera. Serodiagn Immunother Infect Dis 1988; 2:433–444
   [Google Scholar]
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–685
    [Google Scholar]
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350–4354
    [Google Scholar]
12. Andrews AT. Electrophoresis: theory, techniques, and biochemical and clinical applications. , 2nd edn. Peacocke AR, Harrington WF. (eds) Monographs on physical biochemistry Oxford: Clarendon Press; 1986
    [Google Scholar]
13. Brodeur BR, Tsang P, Larose Y. Parameters affecting ascites tumour formation in mice and monoclonal antibody production. J Immunol Methods 1984; 71:265–272
    [Google Scholar]
14. Calandra T, Glauser MP, Schellekens J. Verhoef J and Swiss-Dutch Immunoglobulin Study Group Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis 1988; 158:312–319
    [Google Scholar]
15. Chedid L, Parant M, Parant F, Boyer F. A proposed mechanism for natural immunity to enterobacteria pathogens. J Immunol 1968; 100:292–301
    [Google Scholar]
16. Ziegler EJ, McCutchan JA, Fierer J. et al. Treatment of gram-negative bacteraemia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307:1225–1230
    [Google Scholar]
17. Johns M, Skehill A, McCabe WR. Immunization with rough mutants of Salmonella minnesota IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis 1983; 147:57–67
    [Google Scholar]
18. Leying H, Suerbaum S, Kroll HP, Karch H, Opferkuch W. Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane. Antimicrob Agents Chemother 1986; 30:475–480
    [Google Scholar]
19. Zak O, Kradolfer F. Effect of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis 1979; 1:862–879
    [Google Scholar]
20. Overbeek BP, de Vos NM, Schellekens JFP, Rozenberg-Arska M, Verhoef J. Beta-lactam antibiotics enhance the building of antibodies to outer membrane, non LPS antigenic structures in Enterobacteriaceae. Serodiagn Immunother Infect Dis 1989; 3:175–183
    [Google Scholar]
21. Hofstra H, van Tol MJD, Dankert J. Cross-reactivity of major outer membrane proteins of Enterobacteriaceae, studied by crossed immunoelectrophoresis. J Bacteriol 1980; 143:328–337
    [Google Scholar]
22. Màkelà PH, Kuusi N, Nurminen M, Saxen H, Valtonen M. Porins: the major outer membrane proteins of enteric bacteria as protective antigens. Semin Infect Dis 1982; 4:360–365
    [Google Scholar]
23. Udhaiyakumar V, Muthukkaruppan VR. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice. Infect Immun 1987; 55:816–821
    [Google Scholar]